serw-MX  [xml]  
 


    
 DeCS Categories

C10 Nervous System Diseases .
C10.597 Neurologic Manifestations .
C10.597.606 Neurobehavioral Manifestations .
C10.597.606.150 Communication Disorders .
C10.597.606.150.500 Language Disorders .
C10.597.606.150.500.800 Speech Disorders .
C10.597.606.150.500.800.750 Stuttering .
C23 Pathological Conditions, Signs and Symptoms .
C23.888 Signs and Symptoms .
C23.888.592 Neurologic Manifestations .
C23.888.592.604 Neurobehavioral Manifestations .
C23.888.592.604.150 Communication Disorders .
C23.888.592.604.150.500 Language Disorders .
C23.888.592.604.150.500.800 Speech Disorders .
C23.888.592.604.150.500.800.750 Stuttering .
D02 Organic Chemicals .
D02.540 Lactones .
D02.540.505 Macrolides .
D02.540.505.575 Nystatin .
D04 Polycyclic Compounds .
D04.210 Fused-Ring Compounds .
D04.210.500 Steroids .
D04.210.500.247 Cholestanes .
D04.210.500.247.222 Cholestenes .
D04.210.500.247.222.222 Cholestadienes .
D04.210.500.247.222.222.347 Cholestadienols .
D04.210.500.247.222.222.347.389 Fusidic Acid .
D04.210.500.247.808 Sterols .
D04.210.500.247.808.489 Fusidic Acid .
D09 Carbohydrates .
D09.408 Glycosides .
D09.408.051 Aminoglycosides .
D09.408.051.374 Gentamicins .
D10 Lipids .
D10.570 Membrane Lipids .
D10.570.938 Sterols .
D10.570.938.515 Fusidic Acid .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.519 Molecular Mechanisms of Pharmacological Action .
D27.505.519.186 Antimetabolites .
D27.505.519.186.071 Hypolipidemic Agents .
D27.505.519.186.071.202 Anticholesteremic Agents .
D27.505.519.186.071.202.370 Hydroxymethylglutaryl-CoA Reductase Inhibitors .
D27.505.519.389 Enzyme Inhibitors .
D27.505.519.389.370 Hydroxymethylglutaryl-CoA Reductase Inhibitors .
D27.505.954 Therapeutic Uses .
D27.505.954.557 Lipid Regulating Agents .
D27.505.954.557.500 Hypolipidemic Agents .
D27.505.954.557.500.202 Anticholesteremic Agents .
D27.505.954.557.500.202.370 Hydroxymethylglutaryl-CoA Reductase Inhibitors .
D27.720 Specialty Uses of Chemicals .
D27.720.233 Coloring Agents .
N03 Health Care Economics and Organizations .
N03.349 Health Planning .
N03.349.550 National Health Programs .
N03.349.550.902 State Medicine .
N03.858 State Medicine .
SP4 Environmental Health .
SP4.011 Science .
SP4.011.097 Chemistry .
SP4.011.097.006 Coloring Agents .
SP9 Health Law .
SP9.040 Constitutional Law .
SP9.040.010 State .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Nystatin .
Fungicidin .
Mycostatin .
Nilstat .
Nystatin A1 .
Nystatin A2 .
Nystatin A3 .
Nystatin G .
Stamicin .
Stamycin .
Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3. .
1.00
832782
 
State .
Organization of a people with their own territory and GOVERNMENT to perform individual and collective purposes, with sovereignty. .
0.57
1950
 
Fusidic Acid .
Fucithalmic .
Fusidate Sodium .
Fusidic Acid, Sodium Salt .
Fusidin .
Silver Fusidate .
Sodium Fusidate .
Stanicide .
Acid, Fusidic .
Fusidate, Silver .
Fusidate, Sodium .
Sodium, Fusidate .
An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed). It acts by inhibiting translocation during protein synthesis. .
0.54
151478
 
Stuttering .
Stuttering, Acquired .
Stuttering, Adult .
Stuttering, Childhood .
Stuttering, Developmental .
Stuttering, Familial Persistent 1 .
Acquired Stuttering .
Adult Stuttering .
Childhood Stuttering .
Developmental Stuttering .
Stammering .
A disturbance in the normal fluency and time patterning of speech that is inappropriate for the individual's age. This disturbance is characterized by frequent repetitions or prolongations of sounds or syllables. Various other types of speech dysfluencies may also be involved including interjections, broken words, audible or silent blocking, circumlocutions, words produced with an excess of physical tension, and monosyllabic whole word repetitions. Stuttering may occur as a developmental condition in childhood or as an acquired disorder which may be associated with BRAIN INFARCTIONS and other BRAIN DISEASES. (From DSM-IV, 1994) .
0.53
1333158
 
Gentamicins .
G-Myticin .
Garamycin .
Gentacycol .
Gentamicin .
Gentamicin Sulfate .
Gentamycins .
Gentavet .
Genticin .
G Myticin .
GMyticin .
Sulfate, Gentamicin .
Gentamycin .
Gentamicin Sulfate (USP) .
Gentamicin Sulfate .
A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS. .
0.52
46517370
 
Coloring Agents .
Organic Pigments .
Pigments, Inorganic .
Inorganic Pigments .
Pigments, Organic .
Stains, Tissue .
Dyes 3424 .
Stains .
Tissue Stains .
Skin Dyes .
Tissue Dyes .
Phthalein Dyes .
Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. .
0.52
39333749
 
Hydroxymethylglutaryl-CoA Reductase Inhibitors .
Inhibitors, HMG-CoA Reductase .
Inhibitors, Hydroxymethylglutaryl-CoA .
Inhibitors, Hydroxymethylglutaryl-Coenzyme A .
Statins .
HMG CoA Reductase Inhibitors .
HMG-CoA Statins .
Hydroxymethylglutaryl CoA Reductase Inhibitors .
Hydroxymethylglutaryl-CoA Inhibitors .
Hydroxymethylglutaryl-Coenzyme A Inhibitors .
Inhibitors, HMG CoA Reductase .
Inhibitors, Hydroxymethylglutaryl CoA .
Inhibitors, Hydroxymethylglutaryl Coenzyme A .
Inhibitors, Hydroxymethylglutaryl-CoA Reductase .
Reductase Inhibitors, HMG-CoA .
Reductase Inhibitors, Hydroxymethylglutaryl-CoA .
Statins, HMG CoA .
HMG-CoA Reductase Inhibitors .
Statins, HMG-CoA .
Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis. .
0.51
28625679
 
State Medicine .
British Health Service, National .
British National Health Service .
Medicine, Socialized .
Medicine, State .
Service, British National Health .
National Health Service, British .
Socialized Medicine .
A system of medical care regulated, controlled and financed by the government, in which the government assumes responsibility for the health needs of the population. .
0.51
7753268